AstraZeneca PLC AZN
HEALTHCARE · DRUG MANUFACTURERS - GENERALi
Market dataready · fetched 2026-11-08T00:51:31.518Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-07T00:00:00.001658909Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-08T00:51:31.011067+00:00
AstraZeneca PLC options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 195.54 | 27.9% | 5.5% | 177.79 | 30.9% | 5.3% |
| 25Δ | 193.88 | 28.1% | 4.8% | 179.97 | 30.0% | 4.3% |
| 30Δ | 192.42 | 28.3% | 4.2% | 181.44 | 29.5% | 3.8% |
| 35Δ | 190.97 | 28.6% | 3.7% | 182.90 | 29.0% | 3.2% |
| 40Δ | 189.56 | 28.8% | 3.2% | 184.36 | 28.6% | 2.7% |
| 45Δ | 188.27 | 28.9% | 2.8% | 185.71 | 28.3% | 2.3% |
| 50Δ | 186.97 | 29.1% | 2.5% | 186.97 | 28.3% | 2.0% |
| 55Δ | 185.67 | 29.3% | 2.1% | 188.23 | 28.2% | 1.7% |
| 60Δ | 184.31 | 29.4% | 1.8% | 189.50 | 28.1% | 1.3% |
| 65Δ | 182.87 | 29.6% | 1.5% | 190.99 | 28.4% | 1.1% |
| 70Δ | 181.43 | 29.8% | 1.3% | 192.63 | 29.0% | 0.9% |
| 75Δ | 179.98 | 30.0% | 1.0% | 194.27 | 29.6% | 0.7% |
| 80Δ | 178.00 | 30.2% | 0.8% | 196.43 | 30.3% | 0.5% |
20Δ
- Pseudo strike
- 195.54
- IV
- 27.9%
- B/E move
- 5.5%
- Pseudo strike
- 177.79
- IV
- 30.9%
- B/E move
- 5.3%
25Δ
- Pseudo strike
- 193.88
- IV
- 28.1%
- B/E move
- 4.8%
- Pseudo strike
- 179.97
- IV
- 30.0%
- B/E move
- 4.3%
30Δ
- Pseudo strike
- 192.42
- IV
- 28.3%
- B/E move
- 4.2%
- Pseudo strike
- 181.44
- IV
- 29.5%
- B/E move
- 3.8%
35Δ
- Pseudo strike
- 190.97
- IV
- 28.6%
- B/E move
- 3.7%
- Pseudo strike
- 182.90
- IV
- 29.0%
- B/E move
- 3.2%
40Δ
- Pseudo strike
- 189.56
- IV
- 28.8%
- B/E move
- 3.2%
- Pseudo strike
- 184.36
- IV
- 28.6%
- B/E move
- 2.7%
45Δ
- Pseudo strike
- 188.27
- IV
- 28.9%
- B/E move
- 2.8%
- Pseudo strike
- 185.71
- IV
- 28.3%
- B/E move
- 2.3%
50Δ
- Pseudo strike
- 186.97
- IV
- 29.1%
- B/E move
- 2.5%
- Pseudo strike
- 186.97
- IV
- 28.3%
- B/E move
- 2.0%
55Δ
- Pseudo strike
- 185.67
- IV
- 29.3%
- B/E move
- 2.1%
- Pseudo strike
- 188.23
- IV
- 28.2%
- B/E move
- 1.7%
60Δ
- Pseudo strike
- 184.31
- IV
- 29.4%
- B/E move
- 1.8%
- Pseudo strike
- 189.50
- IV
- 28.1%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 182.87
- IV
- 29.6%
- B/E move
- 1.5%
- Pseudo strike
- 190.99
- IV
- 28.4%
- B/E move
- 1.1%
70Δ
- Pseudo strike
- 181.43
- IV
- 29.8%
- B/E move
- 1.3%
- Pseudo strike
- 192.63
- IV
- 29.0%
- B/E move
- 0.9%
75Δ
- Pseudo strike
- 179.98
- IV
- 30.0%
- B/E move
- 1.0%
- Pseudo strike
- 194.27
- IV
- 29.6%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 178.00
- IV
- 30.2%
- B/E move
- 0.8%
- Pseudo strike
- 196.43
- IV
- 30.3%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 28.90% | |
| 28.60% | |
| 27.23% | |
| 27.94% | |
| 26.93% | |
| 28.24% | |
| 29.10% | |
| 31.06% | |
| 27.71% | |
| 27.81% | |
| 27.34% | |
| 28.72% | |
| 29.20% | |
| 28.68% | |
| 28.94% | |
| 28.17% | |
| 29.16% | |
| 29.09% | |
| 29.05% | |
| 31.03% | |
| 30.38% | |
| 31.34% | |
| 31.10% | |
| 29.05% | |
| 29.01% | |
| 30.43% | |
| 28.14% | |
| 28.71% | |
| 27.92% | |
| 28.14% | |
| 28.53% | |
| 27.96% | |
| 28.65% | |
| 28.91% | |
| 29.66% | |
| 31.63% | |
| 31.92% | |
| 32.06% | |
| 31.91% | |
| 32.10% | |
| 31.61% | |
| 31.84% | |
| 33.29% | |
| 33.79% | |
| 34.73% | |
| 33.23% | |
| 32.11% | |
| 32.18% | |
| 31.72% | |
| 32.58% | |
| 32.72% | |
| 31.18% | |
| 30.60% | |
| 30.29% | |
| 30.37% | |
| 27.64% |
Drug Manufacturers - General
BIIB
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the…
More →BMY
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and…
More →GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the…
More →GRFS
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
More →GSK
Description unavailable
More →JNJ
Description unavailable
More →